Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection

PLoS Pathog. 2019 Jul 29;15(7):e1007914. doi: 10.1371/journal.ppat.1007914. eCollection 2019 Jul.

Abstract

Human cytomegalovirus (HCMV) is a ubiquitous pathogen that can cause disability in newborns and serious clinical diseases in immunocompromised patients. HCMV has a large genome with enormous coding potential; its viral particles are equipped with complicated glycoprotein complexes and can infect a wide range of human cells. Although multiple host cellular receptors interacting with viral glycoproteins have been reported, the mechanism of HCMV infection remains a mystery. Here we report identification of adipocyte plasma membrane-associated protein (APMAP) as a novel modulator active in the early stage of HCMV infection. APMAP is necessary for HCMV infection in both epithelial cells and fibroblasts; knockdown of APMAP expression significantly reduced HCMV infection of these cells. Interestingly, ectopic expression of human APMAP in cells refractory to HCMV infection, such as canine MDCK and murine NIH/3T3 cells, promoted HCMV infection. Furthermore, reduction in viral immediate early (IE) gene transcription at 6 h post infection and delayed nucleus translocation of tegument delivered pp65 at 4 h post infection were detected in APMAP-deficient cells but not in the wildtype cells. These results suggest that APMAP plays a role in the early stage of HCMV infection. Results from biochemical studies of APMAP and HCMV proteins suggest that APMAP could participate in HCMV infection through interaction with gH/gL containing glycoprotein complexes at low pH and mediate nucleus translocation of tegument pp65. Taken together, our results suggest that APMAP functions as a modulator promoting HCMV infection in multiple cell types and is an important player in the complex HCMV infection mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / metabolism
  • Adipocytes / virology
  • Animals
  • Cell Membrane / metabolism
  • Cell Membrane / virology
  • Cytomegalovirus / genetics
  • Cytomegalovirus / metabolism
  • Cytomegalovirus / pathogenicity*
  • Cytomegalovirus Infections / etiology
  • Cytomegalovirus Infections / metabolism*
  • Cytomegalovirus Infections / virology*
  • Dogs
  • Epithelial Cells / metabolism
  • Epithelial Cells / virology
  • Fibroblasts / metabolism
  • Fibroblasts / virology
  • Gene Knockout Techniques
  • Host Microbial Interactions
  • Humans
  • Madin Darby Canine Kidney Cells
  • Membrane Glycoproteins / antagonists & inhibitors
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism*
  • Mice
  • NIH 3T3 Cells
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Viral Structural Proteins / metabolism
  • Virulence
  • Virus Internalization

Substances

  • APMAP protein, human
  • Membrane Glycoproteins
  • Recombinant Proteins
  • Viral Structural Proteins

Grants and funding

This study was funded by grants from Merck and Co., Inc. Kenilworth, NJ, USA, the Texas emerging technology fund, and the Welsh Foundation Grant # AU-0042-20030616 (ZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.